| 1 |
Phase 2 Study of Nimotuzumab in Combination With Concurrent Chemoradiotherapy in Patients With Locally Advanced Non–Small-Cell Lung Cancer |
|
| | Nobuyuki Yamamoto, Hideyuki Harada, Isamu Okamoto, Noriyuki Masuda, Kazushige Hayakawa, Miyako Satouchi, Toshinori Soejima, Makoto Nishio, Takuyo Kozuka, Koji Takeda, Masahiro Tanaka, Takashi Seto, Tomonari Sasaki, Hiroshi Tsubouchi, Yasuyuki Kakurai, Yasumasa Nishimura, Kazuhiko Nakagawa | | | Clinical Lung Cancer. 2021; 22(2): 134 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Case Report: Primary and Acquired Resistance Mechanisms of Nimotuzumab in Advanced Esophageal Squamous Cell Carcinoma Revealed by Targeted Sequencing |
|
| | Dantong Sun, Weihua Yan, Hua Zhu, Qiaoling Liu, Helei Hou | | | Frontiers in Oncology. 2020; 10 | | | [Pubmed] [Google Scholar] [DOI] | |
|
